Botanical species · safety record

Trigonella foenum-graecum

The EFSA Compendium of Botanicals holds 3 constituent measurements and 11 adverse-effect records for Trigonella foenum-graecum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Trigonella foenum-graecum L.

3Constituent measurements
11Safety records
7Cited sources
1,168Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 1,168 licensed products naming Trigonella foenum-graecum as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • solid

Source material stated

  • Aged bark
  • Dried ripe seeds
  • Dried seed
  • Fenugreek Seed
  • Grain
  • Grain(s)
  • Graine
  • Leaf

What the records describe

Constituents measured

  • Alkaloids1
  • Saponins1
  • Steroidal saponins1

Plant parts

  • Seed13
  • Unspecified1

Preparations

  • Solvent extraction11
  • Raw, no heat treatment1

Effect types

  • Teratogenic4
  • Reproductive3
  • Hemopoietic1
  • Musclo-skeletal1
  • Other toxicities1
  • Systemic1

Target tissues

  • Uterus2
  • Cardiovascular1
  • Muscle, skeletal1
  • Neurologic1
  • Testes1
  • haematological1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Steroidal saponinsSeedSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
AlkaloidsSeedSolvent extractionPhytochemical screeningNo resolvable identifier
SaponinsSeedSolvent extractionPhytochemical screeningNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
HemopoieticCardiovascular / haematologicalSeedSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI
SystemicSeedSolvent extractionHouse mouse (as animal)Short-term toxicityResolve DOI
TeratogenicSeedSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
TeratogenicSeedSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
TeratogenicSeedSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
TeratogenicSeedSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
Musclo-skeletalMuscle, skeletalUnspecifiedRaw, no heat treatmentRuminants (generic) (as animal)Case reportNo resolvable identifier
Other toxicitiesNeurologicSeedSolvent extractionRat (as animal)Acute toxicityNo resolvable identifier
ReproductiveTestesSeedHouse mouse (as animal)SubchronicNo resolvable identifier
ReproductiveUterusSeedHouse mouse (as animal)SubchronicNo resolvable identifier
ReproductiveUterusSeedSolvent extractionRat (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Shlosberg, A., Egyed, M N. Examples of poisonous plants in Israel of importance to animals and man.. Archives of toxicology. supplement. = archiv fur toxikologie. supplement, 1983, vol. 6, p. 194-6.
  2. Kandhare, Amit D., Bodhankar, Subhash L., Mohan, V., Thakurdesai, Prasad A. Acute and repeated doses (28 days) oral toxicity study of glycosides based standardized fenugreek seed extract in laboratory mice . Regulatory toxicology and pharmacology, 2015, vol. 72, no. 2, p. 323-334. DOI
  3. Al-Yahya, Abdulaziz A. Reproductive, cytological and biochemical toxicity of fenugreek in male Swiss albino mice. African journal of pharmacy and pharmacology, 2013, p. 2072-2080.
  4. Dande, P., Patil, S. Evaluation of saponins from Trigonella foenum graecum seeds for its antifertility activity. Asian journal of pharmaceutical and clinical research, 2012, vol. 5, no. SUPPL. 3, p. 154-157.
  5. Khalki, Loubna., M'hamed, Saadia Ba., Bennis, Mohamed., Chait, Abderrahman., Sokar, Zahra. Evaluation of the developmental toxicity of the aqueous extract from Trigonella foenum-graecum (L.) in mice . Journal of ethnopharmacology, 2010, vol. 131, no. 2, p. 321-325. DOI
  6. Kawabata, Tetsuro., Cui, Ming-Yue., Hasegawa, Tatsuya., Takano, Fumihide., Ohta, Tomihisa. Anti-Inflammatory and Anti-Melanogenic Steroidal Saponin Glycosides from Fenugreek (Trigonella foenum-graecum L.) Seeds . Planta medica, 2011, vol. 77, no. 7, p. 705-710. DOI
  7. Mowla, Asmena., Alauddin, M., Rahman, Md. Atiar., Ahmed, Kabir. ANTIHYPERGLYCEMIC EFFECT OF TRIGONELLA FOENUM-GRAECUM (FENUGREEK) SEED EXTRACT IN ALLOXAN-INDUCED DIABETIC RATS AND ITS USE IN DIABETES MELLITUS: A BRIEF QUALITATIVE PHYTOCHEMICAL AND ACUTE TOXICITY TEST ON THE EXTRACT . African journal of traditional complementary and alternative medicines, 2009, vol. 6, no. 3, p. 255-261.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue